Does neuroimaging research examining the pathophysiology of posttraumatic stress disorder require medication-free patients?

BACKGROUND In an attempt to avoid unknown influence, most neuroimaging studies examining the pathophysiology of posttraumatic stress disorder (PTSD) exclude patients taking medications. Here we review the empirical evidence for relevant medications having a confounding effect on task performance or cerebral blood flow (CBF) in this population. The evidence for potentially confounding effects of psychotherapy in PTSD are also discussed. METHODS The literature that we reviewed was obtained through a PubMed search from 1980 to 2009 using the search terms posttraumatic stress disorder, PTSD, psychotropic medications, neuroimaging, functional magnetic resonance imaging, positron emission tomography, cerebral blood flow, CBF, serotonin-specific reuptake blocker, benzodiazepine, ketamine, methamphetamine, lamotrigine and atypical antipsychotic agents. RESULTS The empirical evidence for relevant medications having a confounding effect on task performance or CBF in relevant areas remains sparse for most psychotropic medications among patients with PTSD. However, considerable evidence is accumulating for 2 of the most commonly prescribed medication classes (serotonin-specific reuptake inhibitors and benzodiazepines) in healthy controls. Compelling data for the potentially confounding effects on brain areas relevant to PTSD for psychotherapeutic interventions are also accumulating. CONCLUSION Neuroimaging studies examining the pathophysiology of PTSD should ideally recruit both medicated (assuming that the medication treatment has not resulted in the remission of symptoms) and unmedicated participants, to allow the findings to be generalized with greater confidence to the entire population of patients with PTSD. More research is needed into the independent effects of medications on task performance and CBF in regions of interest in PTSD. Neuroimaging studies should also take into account whether patients are currently engaged in psychotherapeutic treatment.

[1]  I. Liberzon,et al.  The Neurocircuitry of Fear, Stress, and Anxiety Disorders , 2011, Neuropsychopharmacology.

[2]  X. Mao,et al.  A pilot study of the effects of chronic paroxetine administration on hippocampal N-acetylaspartate in generalized anxiety disorder , 2010, Journal of psychopharmacology.

[3]  Erasing Fear Memories , 2009, Science.

[4]  P. Fox,et al.  Amygdala hyperactivation in untreated depressed individuals , 2009, Psychiatry Research: Neuroimaging.

[5]  B. Oken THE PLACEBO TREATMENTS IN NEUROSCIENCES: NEW INSIGHTS FROM CLINICAL AND NEUROIMAGING STUDIES , 2009, Neurology.

[6]  Catherine J. Harmer,et al.  Effect of a single dose of citalopram on amygdala response to emotional faces , 2009, British Journal of Psychiatry.

[7]  A. Phillips Interference Peptides to Probe Addiction , 2009 .

[8]  J. Zubieta,et al.  Neurobiological Mechanisms of Placebo Responses , 2009, Annals of the New York Academy of Sciences.

[9]  Andreas Meyer-Lindenberg,et al.  Evidence that altered amygdala activity in schizophrenia is related to clinical state and not genetic risk. , 2009, The American journal of psychiatry.

[10]  R. Dolan,et al.  Incidental retrieval of emotional contexts in post-traumatic stress disorder and depression: An fMRI study , 2009, Brain and Cognition.

[11]  C. Damsa,et al.  Current status of brain imaging in anxiety disorders , 2009, Current opinion in psychiatry.

[12]  I. Black,et al.  The Effect of Propranolol on Posttraumatic Stress Disorder in Burned Service Members , 2009, Journal of burn care & research : official publication of the American Burn Association.

[13]  M. Kopeček,et al.  The Change of Regional Brain Metabolism (18 FDG PET) in Panic Disorder During The Treatment with Cognitive Behavioral Therapy or Antidepressants , 2004, NeuroImage.

[14]  J. Vázquez-Barquero,et al.  Effect of antipsychotic drugs on brain morphometry. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[15]  C. Goetz,et al.  The placebo treatments in neurosciences , 2008, Neurology.

[16]  Andreas Heinz,et al.  Switching schizophrenia patients from typical neuroleptics to olanzapine: Effects on BOLD response during attention and working memory , 2008, European Neuropsychopharmacology.

[17]  Aina Puce,et al.  Abnormal recruitment of working memory updating networks during maintenance of trauma-neutral information in post-traumatic stress disorder , 2008, Psychiatry Research: Neuroimaging.

[18]  Yuchiao Chang,et al.  Presence and acquired origin of reduced recall for fear extinction in PTSD: results of a twin study. , 2008, Journal of psychiatric research.

[19]  R. Rosenheck,et al.  Pharmacotherapy of PTSD in the U.S. Department of Veterans Affairs: diagnostic- and symptom-guided drug selection. , 2008, The Journal of clinical psychiatry.

[20]  Alain Brunet,et al.  Effect of post-retrieval propranolol on psychophysiologic responding during subsequent script-driven traumatic imagery in post-traumatic stress disorder. , 2008, Journal of psychiatric research.

[21]  Y. Kawasaki,et al.  Electrophysiological basis for the ability of olanzapine to improve verbal memory and functional outcome in patients with schizophrenia: A LORETA analysis of P300 , 2008, Schizophrenia Research.

[22]  D. Kupfer,et al.  Medication effects in neuroimaging studies of bipolar disorder. , 2008, The American journal of psychiatry.

[23]  P. Cowen,et al.  Direct effects of diazepam on emotional processing in healthy volunteers , 2007, Psychopharmacology.

[24]  C. Sripada,et al.  The functional neuroanatomy of PTSD: a critical review. , 2008, Progress in brain research.

[25]  A. Simmons,et al.  Escitalopram effects on insula and amygdala BOLD activation during emotional processing , 2008, Psychopharmacology.

[26]  M. Phillips,et al.  Neuroimaging in bipolar disorder: A critical review of current findings , 2007, Current psychiatry reports.

[27]  M. Stein,et al.  Pharmacotherapy to prevent PTSD: Results from a randomized controlled proof-of-concept trial in physically injured patients. , 2007, Journal of traumatic stress.

[28]  John Suckling,et al.  A Longitudinal Functional Magnetic Resonance Imaging Study of Verbal Working Memory in Depression After Antidepressant Therapy , 2007, Biological Psychiatry.

[29]  M. Dewey,et al.  Claustrophobia during magnetic resonance imaging: Cohort study in over 55,000 patients , 2007, Journal of magnetic resonance imaging : JMRI.

[30]  A. Etkin,et al.  Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. , 2007, The American journal of psychiatry.

[31]  D. Salmaso,et al.  Effects of EMDR psychotherapy on 99mTc-HMPAO distribution in occupation-related post-traumatic stress disorder , 2007, Nuclear medicine communications.

[32]  Dominique Cardebat,et al.  Paroxetine-induced modulation of cortical activity supporting language representations of action , 2007, Psychopharmacology.

[33]  H. Uylings,et al.  Effects of psychotherapy on regional cerebral blood flow during trauma imagery in patients with post-traumatic stress disorder: a randomized clinical trial , 2007, Psychological Medicine.

[34]  Iris Eshed,et al.  Claustrophobia and premature termination of magnetic resonance imaging examinations , 2007, Journal of magnetic resonance imaging : JMRI.

[35]  R. Griffiths,et al.  Differential effects of scopolamine and lorazepam on working memory maintenance versus manipulation processes , 2007, Cognitive, affective & behavioral neuroscience.

[36]  P. Cowen,et al.  Short-term antidepressant treatment and facial processing , 2007, British Journal of Psychiatry.

[37]  Sidney H. Kennedy,et al.  Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. , 2007, The American journal of psychiatry.

[38]  Helen S. Mayberg,et al.  Defining the Neural Circuitry of Depression: Toward a New Nosology With Therapeutic Implications , 2007, Biological Psychiatry.

[39]  A. Newberg,et al.  Cerebral blood flow changes during retrieval of traumatic memories before and after psychotherapy: a SPECT study , 2007, Psychological Medicine.

[40]  K. Felmingham,et al.  Changes in Anterior Cingulate and Amygdala After Cognitive Behavior Therapy of Posttraumatic Stress Disorder , 2007, Psychological science.

[41]  J. Bremner,et al.  Functional neuroimaging studies in posttraumatic stress disorder: review of current methods and findings , 2007, Depression and anxiety.

[42]  S. Orr,et al.  Neurocognitive function in monozygotic twins discordant for combat exposure: relationship to posttraumatic stress disorder. , 2006, Journal of abnormal psychology.

[43]  James Robert Brašić,et al.  Dose effects of triazolam on brain activity during episodic memory encoding: a PET study , 2006, Psychopharmacology.

[44]  R. Lanius,et al.  Toward a Psychobiology of Posttraumatic Self‐Dysregulation , 2006, Annals of the New York Academy of Sciences.

[45]  Israel Liberzon,et al.  Neuroimaging Studies of Emotional Responses in PTSD , 2006, Annals of the New York Academy of Sciences.

[46]  S. Rauch,et al.  Amygdala, Medial Prefrontal Cortex, and Hippocampal Function in PTSD , 2006, Annals of the New York Academy of Sciences.

[47]  Guy M. Goodwin,et al.  Antidepressant Drug Treatment Modifies the Neural Processing of Nonconscious Threat Cues , 2006, Biological Psychiatry.

[48]  Thomas Straube,et al.  Effects of cognitive-behavioral therapy on brain activation in specific phobia , 2006, NeuroImage.

[49]  N. Donegan,et al.  Preliminary evidence for medication effects on functional abnormalities in the amygdala and anterior cingulate in bipolar disorder , 2005, Psychopharmacology.

[50]  B. A. van der Kolk,et al.  Posttraumatic stress disorder treatment outcome research: The study of unrepresentative samples? , 2005, Journal of traumatic stress.

[51]  Rebecca Elliott,et al.  The Effect of Citalopram Pretreatment on Neuronal Responses to Neuropsychological Tasks in Normal Volunteers: An fMRI Study , 2005, Neuropsychopharmacology.

[52]  François Chollet,et al.  Modulation of behavior and cortical motor activity in healthy subjects by a chronic administration of a serotonin enhancer , 2005, NeuroImage.

[53]  Nina Mazar,et al.  Probing reward function in post-traumatic stress disorder with beautiful facial images , 2005, Psychiatry Research.

[54]  C. Nemeroff,et al.  Effects of phenytoin on memory, cognition and brain structure in post-traumatic stress disorder: a pilot study , 2005, Journal of psychopharmacology.

[55]  Justin S. Feinstein,et al.  Dose-dependent decrease of activation in bilateral amygdala and insula by lorazepam during emotion processing. , 2005, Archives of general psychiatry.

[56]  John Suckling,et al.  Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. , 2004, Archives of general psychiatry.

[57]  J. Cohn,et al.  Interleaved Transcranial Magnetic Stimulation/Functional MRI Confirms that Lamotrigine Inhibits Cortical Excitability in Healthy Young Men , 2004, Neuropsychopharmacology.

[58]  Dan J Stein,et al.  Single photon emission computed tomography in posttraumatic stress disorder before and after treatment with a selective serotonin reuptake inhibitor. , 2004, Journal of affective disorders.

[59]  P. Nishith,et al.  The Accumulative Effect of Trauma Exposure on Short-Term and Delayed Verbal Memory in a Treatment-Seeking Sample of Female Rape Victims , 2004, Journal of traumatic stress.

[60]  Mark Lau,et al.  Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. , 2004, Archives of general psychiatry.

[61]  R. Clark,et al.  Prescribing patterns for patients with posttraumatic stress disorder. , 2003, Psychiatric services.

[62]  Steven M. Southwick,et al.  Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder , 2003, Biological Psychiatry.

[63]  P. Renshaw,et al.  Selective serotonin reuptake inhibitor discontinuation syndrome is associated with a rostral anterior cingulate choline metabolite decrease: a proton magnetic resonance spectroscopic imaging study , 2003, Biological Psychiatry.

[64]  Gregory G Brown,et al.  An fMRI study of affective state and medication on cortical and subcortical brain regions during motor performance in bipolar disorder , 2003, Psychiatry Research: Neuroimaging.

[65]  W. Drevets Neuroimaging Abnormalities in the Amygdala in Mood Disorders , 2003, Annals of the New York Academy of Sciences.

[66]  R. Lanius,et al.  Stage-Oriented Trauma Treatment Using Dialectical Behaviour Therapy , 2003, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[67]  F. Hu,et al.  Physiologic responses to sudden, loud tones in monozygotic twins discordant for combat exposure: association with posttraumatic stress disorder. , 2003, Archives of general psychiatry.

[68]  Johanne Lévesque,et al.  “Change the mind and you change the brain”: effects of cognitive-behavioral therapy on the neural correlates of spider phobia , 2003, NeuroImage.

[69]  Steve Williams,et al.  Ketamine and fMRI BOLD signal: Distinguishing between effects mediated by change in blood flow versus change in cognitive state , 2003, Human brain mapping.

[70]  C. Kilts In vivo neuroimaging correlates of the efficacy of paroxetine in the treatment of mood and anxiety disorders. , 2003, Psychopharmacology bulletin.

[71]  Philip D. Harvey,et al.  Memory performance in Holocaust survivors with posttraumatic stress disorder. , 2002, The American journal of psychiatry.

[72]  T. Furmark,et al.  Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. , 2002, Archives of general psychiatry.

[73]  L. Cahill,et al.  Pilot study of secondary prevention of posttraumatic stress disorder with propranolol , 2002, Biological Psychiatry.

[74]  J. Vasterling,et al.  Attention, learning, and memory performances and intellectual resources in Vietnam veterans: PTSD and no disorder comparisons. , 2002, Neuropsychology.

[75]  M. Ernst,et al.  Effects of Triazolam on Brain Activity During Episodic Memory Encoding: A PET Study , 2001, Neuropsychopharmacology.

[76]  M. Mintun,et al.  Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study , 2001, Biological Psychiatry.

[77]  Carol A. Tamminga,et al.  Sequential Regional Cerebral Blood Flow Brain Scans Using PET with H215O Demonstrate Ketamine Actions in CNS Dynamically , 2001, Neuropsychopharmacology.

[78]  E. Kaplan,et al.  Qualitative Block Design Analysis in Posttraumatic Stress Disorder , 2000, Assessment.

[79]  J. Vasterling,et al.  Olfactory Identification in Combat-Related Posttraumatic Stress Disorder , 2000, Journal of traumatic stress.

[80]  A. Mathews,et al.  Reduction of anxiety during MR imaging: a controlled trial. , 2000, Magnetic resonance imaging.

[81]  François Chollet,et al.  Cerebral Functional Magnetic Resonance Imaging Activation Modulated by a Single Dose of the Monoamine Neurotransmission Enhancers Fluoxetine and Fenozolone during Hand Sensorimotor Tasks , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[82]  A. Kleinschmidt,et al.  Effects of sedation, stimulation, and placebo on cerebral blood oxygenation: a magnetic resonance neuroimaging study of psychotropic drug action , 1999, NMR in biomedicine.

[83]  D. Kupfer,et al.  Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression. , 1999, The American journal of psychiatry.

[84]  S. Orr,et al.  Psychophysiologic assessment of women with posttraumatic stress disorder resulting from childhood sexual abuse. , 1998, Journal of consulting and clinical psychology.

[85]  T L Strickland,et al.  A review of the neuropsychological effects of commonly used prescription medications. , 1998, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[86]  S. Orr,et al.  Auditory Event-Related Potentials to Tone Stimuli in Combat-Related Posttraumatic Stress Disorder , 1997, Biological Psychiatry.

[87]  L H Staib,et al.  Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder. , 1997, Archives of general psychiatry.

[88]  S. Orr,et al.  Physiologic responses to loud tones in israeli veterans of the 1973 yom kippur war , 1997, Biological Psychiatry.

[89]  D. Perrett,et al.  A differential neural response in the human amygdala to fearful and happy facial expressions , 1996, Nature.

[90]  J. Mazziotta,et al.  Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. , 1992, Archives of general psychiatry.

[91]  S. Mirow Cognitive dysfunction associated with fluoxetine. , 1991, The American journal of psychiatry.